And as a bit more of the story around the Mesoblast acquisition of Angioblast in 2010, this is one of the ASX announcements.
http://www.abnnewswire.net/media/en/docs/62844-ASX-MSB-336282.pdf
The ABC reported that Mesoblast was set to become the largest stem cell developer in the world.
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure
MSB
mesoblast limited
Add to My Watchlist
12.3%
!
$2.43
Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure, page-66
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
